Skip to content

Midatech Pharma US Inc.

Delisted

CIK 919745fmd_1TC8EP8AXSKC6346D99TXGQ9Z0Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2002 to Sep 30, 2015, 30 periods

Latest annual · FY2014

Millions
Total revenues
2
Gross profit
1
Operating income
(9)
Net income
(9)
Free cash flow
(8)

Latest quarter · Q3 FY2015

Millions
Total revenues
1
Gross profit
1
Operating income
(3)
Net income
(3)
Free cash flow
(2)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2011 to FY2014
n/m
Revenue, 5 yearsFY2009 to FY2014
n/m
Net income, 5 yearsFY2009 to FY2014
n/m

Midatech Pharma US Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$1.9 million$419,322+349.9%10-K 2015-03-03 · proof
Gross profit$1.4 million$200,394+620.3%10-K 2015-03-03 · proof
Operating income-$9.4 million-$10.5 million10-K 2015-03-03 · proof
Net income-$9 million-$10 million10-K 2015-03-03 · proof
Cash from operating activities-$8 million-$9.1 million10-K 2015-03-03 · proof
Free cash flow-$8 million-$9.1 million10-K 2015-03-03 · proof
Total assets$17.8 million$8 million+122.2%10-K 2015-03-03 · proof
Total liabilities$3.8 million$2.4 million+58.1%10-K 2015-03-03 · proof
Cash and cash equivalents$12 million$3.4 million+251.1%10-K 2015-03-03 · proof
What was Midatech Pharma US Inc.'s revenue in fiscal 2014?
Midatech Pharma US Inc. reported revenue of $1.9 million for fiscal 2014 (the year ended Dec 31, 2014), against $419,322 the year before (+349.9%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What was Midatech Pharma US Inc.'s gross profit in fiscal 2014?
Midatech Pharma US Inc. reported gross profit of $1.4 million for fiscal 2014 (the year ended Dec 31, 2014), against $200,394 the year before (+620.3%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What was Midatech Pharma US Inc.'s operating income in fiscal 2014?
Midatech Pharma US Inc. reported operating income of -$9.4 million for fiscal 2014 (the year ended Dec 31, 2014), against -$10.5 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What was Midatech Pharma US Inc.'s net income in fiscal 2014?
Midatech Pharma US Inc. reported net income of -$9 million for fiscal 2014 (the year ended Dec 31, 2014), against -$10 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What was Midatech Pharma US Inc.'s cash from operating activities in fiscal 2014?
Midatech Pharma US Inc. reported cash from operating activities of -$8 million for fiscal 2014 (the year ended Dec 31, 2014), against -$9.1 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What was Midatech Pharma US Inc.'s free cash flow in fiscal 2014?
Midatech Pharma US Inc. reported free cash flow of -$8 million for fiscal 2014 (the year ended Dec 31, 2014), against -$9.1 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What are Midatech Pharma US Inc.'s total assets?
As of Dec 31, 2014, Midatech Pharma US Inc. reported total assets of $17.8 million, against $8 million a year earlier (+122.2%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What are Midatech Pharma US Inc.'s total liabilities?
As of Dec 31, 2014, Midatech Pharma US Inc. reported total liabilities of $3.8 million, against $2.4 million a year earlier (+58.1%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
What are Midatech Pharma US Inc.'s cash and cash equivalents?
As of Dec 31, 2014, Midatech Pharma US Inc. reported cash and cash equivalents of $12 million, against $3.4 million a year earlier (+251.1%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:919745&period_type=annual&limit=5"

Information only, not investment advice.